Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losartan with Chemoradiation in Locally Advanced Pancreatic Cancer
NCT05861336Phase 2Withdrawn
- Sponsor
- Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori"
- Start
- Jun 2023
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of losartan in pancreatic cancer (PC), sponsored by Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori". Planned start Jun 2023; status: withdrawn.
02
Drugs
losartan
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT05861336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05861336.